The Board of Directors of the African Development Bank on Monday approved a $10 million loan to the Republic of Seychelles to support the government’s COVID-19 response program.
Diseases
Novartis expands Africa Sickle Cell Disease program to Uganda and Tanzania
New collaborations aim to reduce the burden of sickle cell disease (SCD) in East Africa and improve access to high quality care; Program continues progress in Ghana with more than 2000 patients being treated with hydroxyurea in 11 treatment centers across the country; Novartis (www.Novartis.com) plans to roll the program out to a total of 10 African countries by 2022; Approximately 1 000 children in Africa are born with SCD every day and more than half will die before they reach the age of five.
Combination of healthy lifestyle traits may substantially reduce Alzheimer’s
Combining more healthy lifestyle behaviors was associated with substantially lower risk for Alzheimer’s disease in a study that included data from nearly 3,000 research participants.
NIH launches analytics platform to harness nationwide COVID-19 patient data to speed treatments
The National Institutes of Health has launched a centralized, secure enclave to store and study vast amounts of medical record data from people diagnosed with coronavirus disease across the country.
NIH study links cigarette smoking to higher stroke risk in African Americans
African Americans who smoke are nearly 2.5 times more likely to have a stroke than those who never smoked, while former smokers show a similarly lower risk as never smokers, according to a new study funded by the National Institutes of Health.
Researchers closer to treat severe respiratory distress in patients with COVID-19
Early data from a clinical study suggest that blocking the Bruton tyrosine kinase (BTK) protein provided clinical benefit to a small group of patients with severe COVID-19.
NIH to test one-dose antibiotic for the prevention of maternal and infant sepsis
Researchers supported by the National Institutes of Health and the Bill & Melinda Gates Foundation will assess whether a single oral dose of the antibiotic azithromycin during labor reduces the risk of maternal and infant bacterial infection and death in seven low- and middle-income countries.
